Thomas Dittrich
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas Dittrich
Thomas Dittrich is recorded as CFO at Amgen Inc (AMGN). Amgen Inc reported in an 8-K filed May 19, 2026 that Thomas Dittrich was appointed executive vice president, effective July 1, 2026. Amgen Inc reported in an 8-K filed May 19, 2026 that Thomas Dittrich was appointed Executive Vice President and Chief Financial Officer, effective September 1, 2026.
“Thomas Dittrich will return to Amgen as executive vice president on July 1 and succeed Griffith as chief financial officer effective September 1, 2026.”
“Effective September 1, 2026, he will serve as Executive Vice President and Chief Financial Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-09-01–present
-
Amgen Inc (AMGN)
SEC 8-K
Current2026-07-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Amgen Inc
Other people whose current roles at this company are on record from its filings.
- Robert Bradway CEO
- David W. Meline CFO
- David M. Reese, M.D. CTO
- Sean Bruich CTO
- Jonathan P. Graham General Counsel
- Linda H. Louie Chief Accounting Officer
- Matthew C. Busch Chief Accounting Officer
- Amy E. Miles Board Member
- Michael V. Drake Board Member
- S. Omar Ishrak Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.